Report Highlights
The global market for blood screening and typing should grow from $7.7 billion in 2018 to reach $9.9 billion by 2023 at a compound annual growth rate (CAGR) of 5.0% for the period of 2018-2023.
Report Includes
- 31 data tables and 34 additional tables
- An overview of recent key developments in the global blood screening and typing market and a look ahead at the next five years
- Analyses of global market trends with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Quantitative data covering the overall market by analyzers, kits, reagents and consumables, immunoassay techniques, technology types, microbiology techniques, blood types and consumer groups
- Regional dynamics of the blood screening market covering North America, Europe, Asia-Pacific and Rest of the world including countries of South America, Middle East and Africa
- Study of impact analysis and discussion of technological, regulatory, and economic trends that are affecting the global blood screening market
- Company profiles of the leading market players, including Abbott Laboratories, Becton, Dickinson and Co., Bio-Rad Laboratories, Danaher Corp. and Thermo Fisher Scientific, Inc.
Report Scope
This report focuses on the screening and analysis of donor blood and patient blood. It covers the current market dynamics and various forces that are impacting the market. Two markets are analyzed: blood screening and blood typing. By technology, the blood screening market is segmented into serological technologies Enzyme linked immunosorbent assay (ELISA) and chemiluminescence immunoassay (CLIA), agglutination tests such as gel card agglutination, microplate-based agglutination, and lateral flow tests), nucleic acid amplification technologies (PCR-based and non-PCR based), microbiology techniques (blood culture and antimicrobial susceptibility tests) and niche technologies such as microarray, DNA sequencing.
By blood supply, the market is segmented into patient blood and donor blood. Patient blood supply analysis covers the qualitative detection of infectious diseases such as sexually transmitted diseases and blood-borne infections like sepsis, and blood grouping and typing analysis tests. Donor blood testing involves analysis of donor blood units, including infectious disease screening and blood grouping tests.
By end-user the market is segmented into hospitals, standalone blood banks and reference laboratories. By region, the blood screening and typing market is segmented into North America, Europe, the Asia-Pacific region and Rest of the World (ROW). ROW includes South America, the Middle East and Africa. This report also covers the competitive landscape, detailing the companies engaged in offering products for blood screening and typing. Detailed profiles of the top leading companies are also included.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Anesthesia and Respiratory Devices: Global Markets (HLC167E)
- Global Quantum Batteries Market (FCB074A)
- Chromatography in Pharmaceuticals and Biotechnology: Global Markets (BIO163B)
- Global MedTech Healthcare IT Industry Competitive Landscape (MDS068B)
- Therapies for Rheumatoid Arthritis: Technologies and Global Markets (PHM072B)
Related Reports
Global Blood Platelet Market
The global market for blood platelets is expected to grow from $3.2 billion in 2025 and is projected to reach $4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 4.6% during the forecast period of 2025 to 2030.
Drugs and Diagnostics for Hematological Disorders: Global Markets
The global market for drugs and diagnostics for hematological disorders is expected to grow from $131.2 billion in 2024 and is projected to reach $189.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2024 to 2029.
Chagas Disease: American trypanosomiasis Market
The report provides detailed coverage of the Chagas Disease market. It analyzes the market trends and epidemiology of CD, and the regional markets of CD. It highlights the current market for CD and gives a detailed analysis of the competitive environment. The report depicts the complete scenario of Chagas Disease, types of parasites that cause human African trypanosomiasis (HAT) and its presence in various regions of the world.
Sleeping Sickness - Human African Trypanosomiasis (HAT) Market
The report provides an overview of the sleeping sickness market. It analyzes the epidemiology, geographical markets, and market trends. It also highlights the current market for sleeping sickness, and gives a detailed analysis of the competitive environment. The report depicts the complete scenario of sleeping sickness, types of parasites that cause HAT, and its presence in the regions of the world.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Anesthesia and Respiratory Devices: Global Markets
The global market for anesthesia and respiratory devices is expected to grow from $51.9 billion in 2025 and is projected to reach $74.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2025 to 2030.
Tissue Engineering and Regeneration: Technologies and Global Markets
The global market for tissue engineering and regeneration was valued at $4.8 billion in 2024 and is estimated to increase from $5.4 billion in 2025 to reach $9.8 billion by 2030, at a compound annual growth rate (CAGR) of 12.8% from 2025 through 2030.
6G in Healthcare: Global Market
This report provides an analysis of the global market trends for 6G in healthcare. It focuses on the significant driving trends and challenges that affect the global market. The report concludes with an analysis of the competitive landscape, which provides the ranking/share of key companies in the global market for 6G in healthcare.
Healthcare Innovation in the GCC
The report provides an analysis of the healthcare landscape in the Gulf Cooperation Council (GCC) countries. The report estimates the Total Addressable Market (TAM) for the GCC healthcare sector from 2024 to 2030, offering country-specific projections. This analysis provides critical insights into the commercial potential and investment opportunities in the region’s rapidly evolving healthcare ecosystem. The countries included in the analysis are Saudi Arabia, the United Arab Emirates (UAE), Qatar, Kuwait, Oman, and Bahrain.
Regional Analysis of the Beauty and Personal Care Market: Middle East and North Africa
This report presents an in-depth analysis of the MENA beauty and personal care market, highlighting its current and future potential. It provides a detailed examination of market drivers, restraints, challenges, opportunities, and market projections for 2030.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More